- Home
- PSO vs BIRK Comparison
PSO vs BIRK Comparison
Compare PSO & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PSO | BIRK |
|---|---|---|
| Founded | 1844 | 1774 |
| Country | United Kingdom | United Kingdom |
| Employees | 17116 | N/A |
| Industry | Books | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.0B |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | PSO | BIRK |
|---|---|---|
| Price | $13.06 | $37.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 14 |
| Target Price | N/A | ★ $62.69 |
| AVG Volume (30 Days) | 994.8K | ★ 2.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.50% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.90 | $13.71 |
| Revenue Next Year | $4.88 | $14.21 |
| P/E Ratio | ★ $14.05 | $17.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.02 | $35.70 |
| 52 Week High | $16.70 | $57.39 |
Technical Indicators
Market Signals| Indicator | PSO | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 54.72 | 40.97 |
| Support Level | $12.92 | N/A |
| Resistance Level | $13.34 | $42.19 |
| Average True Range (ATR) | 0.23 | 1.62 |
| MACD | 0.05 | -0.44 |
| Stochastic Oscillator | 68.99 | 20.55 |
Price Performance
Historical ComparisonAbout PSO Pearson Plc
UK-listed Pearson is a testing and educational provider. Pearson's primary operations are in assessment and qualification testing and higher education, but they also provide English education and testing, virtual learning, prehiring testing and screening, and upskilling/reskilling. The company divested noncore businesses, including the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider.
About BIRK Birkenstock Holding plc
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.